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Amaryllidaceae alkaloids: 
identification and partial 
characterization of montanine 
production in Rhodophiala bifida 
plant
Andressa Reis1, Kevin Magne2,3,5, Sophie Massot2,3, Luciana R. tallini1,4, Marina Scopel1, 
Jaume Bastida4, pascal Ratet2,3 & José A. S. Zuanazzi1
Rhodophiala bifida (R. bifida) is a representative of the Amaryllidaceae plant family and is rich in 
montanine, an alkaloid with high pharmaceutical potential. Despite the interest in these compounds, 
many steps of the biosynthetic pathway have not been elucidated. In this study, we identified the 
alkaloids produced in different organs of R. bifida under different growth conditions, set up the 
conditions for in vitro R. bifida regeneration and initiated the molecular characterization of two R. bifida 
genes involved in alkaloids biosynthesis: the Norbelladine 4′-O-Methyltransferase (RbN4OMT) and the 
Cytochrome P450 (RbCYP96T). We show that montanine is the main alkaloid produced in the different 
R. bifida organs and developed a direct organogenesis regeneration protocol, using twin-scale explants 
cultivated on media enriched with naphthalene acetic acid and benzyladenine. Finally, we analyzed the 
RbN4OMT and RbCYP96T gene expressions in different organs and culture conditions and compared 
them to alkaloid production. In different organs of R. bifida young, adult and regenerated plants, as well 
as under various growing conditions, the transcripts accumulation was correlated with the production 
of alkaloids. This work provides new tools to improve the production of this important pharmaceutical 
compound and for future biotechnological studies.
Plants belonging to the Amaryllidaceae family produce alkaloids that have been extensively studied because of 
their pharmaceutical properties. The genus Rhodophiala (Amaryllidaceae) is endemic in South America and 
contains more than 30 bulbous species showing ornamental potential due to their colorful and attractive flowers. 
These plants usually grow in restricted areas and are geographically isolated1. Amaryllidaceae alkaloids such as 
galanthamine present anticholinesterase activities used for the treatment of Alzheimer’s disease; lycorine presents 
cytotoxicity and antitumor properties. Recently, it was shown that montanine has anxiolytic, antidepressive and 
anticonvulsive activities as well as immunomodulatory properties. Moreover, montanine has acetylcholinesterase 
inhibition, anti-reumatic, antimicrobial and antiproliferative effects. These important pharmaceutical properties 
justify an increasing of interest towards this class of compounds2–10.
Despite all the pharmaceutical interests of the galanthamine molecule and the search for new drugs 
derived from the Amaryllidaceae alkaloids (AmAl), the corresponding biosynthetic pathway is not fully char-
acterized yet. Enzymatic steps remain partially misunderstood, especially for the montanine biosynthesis 
1Laboratory of Pharmacognosy, Department of Raw Material Production, federal University of Rio Grande do Sul, 
90610-000, Porto Alegre, UFRGS, Brazil. 2Institute of Plant Sciences Paris-Saclay IPS2, CNRS, INRA, Université 
Paris-Sud, Université Evry, Université Paris-Saclay, Bâtiment 630, 91405, Orsay, France. 3institute of Plant Sciences 
Paris-Saclay IPS2, Paris Diderot, Sorbonne Paris-Cité, Bâtiment 630, 91405, Orsay, France. 4natural Products 
Group, Faculty of Pharmacy, University of Barcelona, Av. Joan XXIII, 27-31, 08028, Barcelona, Spain. 5Present 
address: Laboratory of Molecular Biology, Department of Plant Sciences, Wageningen University & Research, 6708 
PB, Wageningen, The Netherlands. Correspondence and requests for materials should be addressed to P.R. (email: 
pascal.ratet@ips2.universite-paris-saclay.fr)
Received: 26 September 2018
Accepted: 9 May 2019
Published: xx xx xxxx
opeN
2Scientific RepoRts |          (2019) 9:8471  | https://doi.org/10.1038/s41598-019-44746-7
www.nature.com/scientificreportswww.nature.com/scientificreports/
pathway which is distinct from the galanthamine one. By contrast, montanine is characterized by a unique 
5,11-methanomorphanthridine skeleton11.
AmAl biosynthesis (Fig. 1) starts from an L-phenylalanine (1). The Phenylalanine ammonia-lyase (PAL) 
enzyme generates trans-cinnamic acid (2). The CYP73A1 cytochrome P450 enzyme then produces p-coumaric 
acid (3) which forms 4-hydroxycinnamic acid (caffeic acid) (4) or 4-hydroxybenzaldehyde (5) through the 
action of the CYP98A3. Both molecules can generate protocatechuic aldehyde (6). Caffeic acid is transformed 
by the action of a Vanillin synthase (VpVAN) homolog12–14. Tyrosine decarboxylase transforms L-tyrosine (7) 
in tyramine (8). Tyramine can then be condensed together with protocatechuic aldehyde (6) by an unknown 
enzyme to form a Schiff-base that will be reduced by a reductase to form norbelladine (9). Norbelladine is then 
methylated by Norbelladine 4′-O-Methyltransferase (N4OMT) to form 4′-O-methylnorbelladine (10)14.
The key intermediate step for the multiple biosynthetic pathways producing the various structural types of 
AmAl (Fig. 2) is the 4′-O-methylnorbelladine cyclization by the CYP96T Cytochrome P450 enzyme. This cycli-
zation consists in phenol-phenol oxidative coupling and requires ortho-para’, para-para’ and para-ortho’ C-C 
coupling14–17. The 8-O-demethyloxomaritidine (11) is formed following para-para’ C-C phenol coupling. This 
compound is a dienone intermediate precursor of the alkaloid’s skeleton types such as haemanthamine, tazet-
tine, crinine, narciclasine and montanine. After a reduction of the ketone group, 8-O-demethylmaritidine (12) is 
formed and is a likely precursor of vittatine (13) via methylenedioxy group transformation12,16,18,19.
Studies with R. bifida plants15,20 indicate that 11-hydroxyvittatine (25) (haemanthamine ring system) is 
formed by the addition of a hydroxyl group to the vittatine (13). This molecule might be both the montanine and 
haemanthamine precursors, with biosynthesis of haemanthamine being more efficient (only a methylation of the 
hydroxyl function in C3 of 11-hydroxyvittatine). For montanine (15) formation the rearrangement of the vittatine 
ring system is necessary to promote the methylation of the oxygen in C221–23.
Genes involved in the AmAl biosynthesis are poorly characterized and transcriptomic studies as well as 
genome sequencing were only recently initiated for this plant family24–26. The class I O-methyltransferase 
Norbelladine 4′-O-Methyltransferase (N4OMT) gene was recently identified in Narcissus sp. aff. pseudonarcissus 
by heterologous expression in E. coli27. Also, the gene encoding Cytochrome P450 CYP96T1 responsible for the 
para-para’ phenol coupling reaction generating both haemanthamine and crinine carbon skeletons was charac-
terized in Narcissus28.
Because of the high biotechnological interest for the montanine produced by R. bifida, we identified the alka-
loids produced in this plant, set up in vitro R. bifida regeneration conditions and cloned the RbN4OMT and 
RbCYP96T genes. The gene expression of RbN4OMT and RbCYP96T were analyzed and correlated with alkaloids 
production in different organs of R. bifida young, adult and regenerated plants under different culture conditions. 
This work sets up the bases for further studies aiming at improving the montanine production.
Figure 1. The Amaryllidaceae alkaloid biosynthetic pathway: The AmAl precursor 4′-O-methylnorbelladine 
biosynthetic pathway14. Abrev.: L-Phe (L-phenylalanine), N4OMT (norbelladine 4′-O-methyltransferase) and 
CYP96T1 (Cytochrome P450 enzyme of 4′-O-methylnorbelladine).
3Scientific RepoRts |          (2019) 9:8471  | https://doi.org/10.1038/s41598-019-44746-7
www.nature.com/scientificreportswww.nature.com/scientificreports/
Results
Montanine is the major alkaloid produced in R. bifida. The amount of the different types of alka-
loids produced in R. bifida bulbs, leaves and roots were evaluated using GC-MS analysis (Table 1). Montanine, 
possesses a 5,11-methanomorphanthridine nucleus and differs from the other montanine type alkaloids in the 
substituents at C-2 and C-329. According to our study, montanine (15) was present in all organs and is the most 
abundant alkaloid of the plant, in a range from 49.7 to 88% of Total Ion Current (TIC, Table 1). The highest 
amount was found in roots (74–88% of TIC) and the lowest in leaves (54–56% of TIC). Another study using R. 
bifida bulbs, indicated that the alkaloid extracts contained 92% of montanine2 and only traces (less than 0.20%) 
of vittatine, deoxytazettine, tazettine, pretazettine and 3-epimacronine. In contrast, in our study the amount of 
tazettine (22) was in a range of 1.3 to 13.1% of TIC, with the lowest amount in bulbs (1.3 to 2.9% of TIC) and the 
highest amount in leaves (13.1% of TIC). This compound is a part of the tazettine-type alkaloids, derived from 
the 2-benzopyrano[3,4-c] indole skeletons, widely reported in Narcissus and known as an extraction artifact of 
pretazettine29. Vittatine (or crinine, 13) is an intermediate in narciclasine synthesis and is thus involved in the 
montanine formation. It was found in small concentrations in bulbs and leaves29. Pancracine (23) was the other 
molecule identified in all the analyzed tissues. It belongs to the montanine-type alkaloids identified in the 60’s in 
Pancratium maritimum, Narcissus poeticus and R. bifida30. The amount of this compound ranged from <0.1 to 
13% of TIC, with the lowest yield in roots (<0.1–4.3%) and bulbs (1.3–3.3%) and higher content in leaves with 
11.8 to 13% of TIC. We believe that the differences with previous studies2 may result from different harvesting 
times, places, soil, variety or from different chemotypes related to the species sampled.
The 8-O-demethylmaritidine was detected in the genus Galanthus31 and as trisphaeridine (17), 
5,6-dihydrobicolorine (18), and other traces of unknown molecules were found in our study. The molecule 
5,6-dihydrobicolorine (18) was identified for the first time in Narcissus bicolor and belongs to the phenan-
thridine type alkaloids32,33. Ismine (16) and trisphaeridine (17) are considered as catabolic products from the 
haemanthamine- type skeleton29. Galanthindole (20) contains a non-fused indole ring and might represent an 
artifact of homolycorine or tazettine-type derivatives34. O-methyltazettine (21), 3-O-acetylpancracine (24) which 
possess a montanine type nucleus derived from pancracine30 and 3-epimacronine (25) identified in Sprekelia 
formossisima in the 60’s35 were detected as traces in our study.
Our analysis shows that montanine was the major alkaloid produced in R. bifida and that other molecules 
were found in low amount. For some of them we could identify only the alkaloid type and only one of them could 
not be identified (Table 1).
In vitro R. bifida micropropagation. To initiate the in vitro culture of wild R. bifida plants we first tested 
different sterilization protocols. The disinfection method of the wild plants that used the pre-disinfection with 
sodium hypochlorite 8% allowed the lowest level of contamination and the establishment of about 84% healthy in 
vitro explants (Table 2). This pre-cleaning procedure provided a large reduction of the contamination by probably 
letting the bulbs drying on the outside and to be stored with a reduced number of microorganisms on their sur-
face. This allowed subsequent better disinfection and production of healthy explants.
Figure 2. The montanine biosynthetic pathway: Schematic representation showing the important steps of the 
montanine-type alkaloid formation in Amaryllidaceae plants18,19,21–23.
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The procedure using heat promoted the death of the R. bifida explants, in contrast to the results obtained with 
Narcissus ‘Golden Harvest’36 where the lowest percentage of contamination was obtained using hot water. For 
Narcissus, the treatment decreased contamination from 60% to only 5% without affecting the regeneration neither 
the vitality of explants. Factors related to bulb harvest in different places and seasons of the year as well as bulb 
size may make the surface disinfection of the plant highly variable37.
The use of different concentrations of growth regulators (GR) can control plant tissue proliferation and regen-
eration through cell division, elongation, differentiation and organogenesis. In addition they can modify second-
ary metabolites biosynthesis15. R. bifida calli, shoots and bulbs cultures were established in vitro by testing diverse 
GR contents (Table 3). GR promoted callogenesis at different levels, generating diverse types of calli, from friable 
to dense, but without regeneration capacity for the majority of them. Some of these media also allow explants to 
produce shoots by direct organogenesis or from calli, depending on the growth regulators used.
After 20 days of culture on medium 4, 5 and 8 calli formed on 100, 88 and 100% of explants, respectively. After 
60 days, due to tissue death, callus formation declined to 77, 76 and 78%, respectively (Table 3). After 20 days of 
culture on medium 6, calli formed on 79% of the explants, and at 60 days, this percentage increased, reaching 
the totality of the explants. However, the best results, reaching 100% callogenesis, after both 20 and 60 days, were 
found using the medium 10 (Table 3), containing auxin and cytokinin, as growth regulators.
Compound
Rt 
(min) RI [M]+ Bulbs Leaves Roots
Ismine (16**) 20.61 2267.7 257 <0.1–1.0 <0.1–1.0 <0.1
Trisphaeridine (17) 20.92 2286.6 223 <0.1 <0.1 <0.1
5,6-Dihydrobicolorine (18) 21.62 2330.1 239 <0.1 <0.1 —
m/z 270*a; [M = 343]*b, galanthamine-type*c 23.57 2454.5 343 — — <0.1
m/z 238*a; [M = 301]*b, narciclasine-type*c 23.59 2455.2 301 0.6–1.0 1.2 <0.1
m/z 288*a; [M = 289]*b, galanthamine-type*c 23.70 2463.0 289 — <0.1 —
Vittatine/Crinine (13) 23.89 2475.9 271 1.0–1.22 <0.1 —
Galanthindole (20) 24.23 2498.3 281 <0.1–2.1 <0.1–0.8 —
8-O-Demethylmaritidine (12) 24.40 2509.6 273 <0.1 — —
O-Methyltazettine (21) 25.81 2604.7 345 <0.1–3.3 <0.1 —
Montanine (15) 26.36 2641.4 301 49.7–77.6 53.7–56.3 74–88.0
Tazettine (22) 26.52 2652.4 331 1.3–2.9 13.1 8.5–9.3
m/z 252*a; [M = 343]*b, lycorine-type*c 26.61 2658.2 343 — 11.8 —
m/z 331*a; [M = 331]*b 26.70 2664.4 331 <0.1 — —
Pancracine (23) 27.21 2698.0 287 1.3–3.3 11.8–13.0 <0.1–4.3
3-O-Acetylpancracine (24) 27.77 2736.1 329 — 1.6 —
m/z 270*a; [M = 329]*b, galanthamine-type*c 28.42 2779.3 329 — <0.1 —
3-Epimacronine (25) 28.84 2807.6 329 <0.1 <0.1–1.1 <0.1
m/z 252*a; [M = 369]*b, lycorine-type*c 29.44 2848.0 369 — <0.1 —
m/z 252*a; [M = 369]*b, lycorine-type*c 29.67 2863.1 369 — 4.1–5.0 —
m/z 252*a; [M = 387]*b, lycorine-type*c 31.07 2957.3 387 1.1–2.6 7.2–10.3 <0.1
Table 1. R. bifida alkaloids identified by GC-MS analysis. *aBase peak. *bPossible molecular ion peak. 
*cProposed structure-type according to the fragmentation pattern. **The molecules represented by bold 
numbers in brackets are in the biosynthesis pathways (Figs 1 and 2) or in the online resource, Fig. S3). R. bifida 
alkaloids detected by GC-MS analysis are given as percentage of TIC. TIC (for Total Ion Current) represents the 
amount of the different compounds detected by GC–MS in the different organs and expressed as a percentage 
of the total alkaloids present in R. bifida wild plants grown in a greenhouse. The identification of the alkaloid 
structural types was done by comparing their GC-MS spectra and Kovats Retention Index (RI) values with 
those of authentic AmAls previously isolated and identified by spectrometric methods (NMR, UV, CD, MS). 
The MS spectra were deconvoluted by AMDIS 2.64 software (NIST). Three samples were analyzed for each 
organ. Values are indicated as the proportion of each individual molecule in the alkaloid fractions.
Method Contamination (%)
Sodium hypochlorite 2% 96.67 a
Heating at 54 °C 78.33 b
Pre-disinfection + Sodium hypochlorite 
8% 16.00 c
Table 2. Percentage of contamination in R. bifida bulbs explants using different methods of disinfection. Means 
with different letters are significantly different using Duncan test (p < 0.05).
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For axillary bud development, there were no significant statistical differences after 20 days of treatment, but at 
60 days, the best result was obtained using medium 7, with 31% of explants forming buds. Using media 2 and 9, 25 
and 20% of the explants formed buds (Table 3). These buds could latter develop to shoots and form micro-plants.
The best R. bifida axillary shoot regeneration was obtained with medium 7 (Fig. 3C–H), followed by two 
media with two growth regulator compositions, one containing NAA 0.1 mg/L + BA 5 mg/L and the other with 
higher concentration of sucrose (60 g/L). Before the transfer to the liquid medium, the shoot formation took place 
with aggregates containing 3 to countless micro-plants per explant (Fig. 3K).
For bulbs growth (Fig. 3I), the micro-plants still attached to the explant were transferred to the multiplication 
medium (Fig. 3J,K), passing through different developmental stages, reaching the transfer stage in the liquid 
medium (Fig. 3L,M). This allowed the enlargement of bulb mass and leaf expansion of regenerated plants up to 
the time of acclimation in the greenhouse (Fig. 3N), once the bulb was completely formed.
After 45 days in the multiplication medium, the number of regenerated plants reached 38 plants/explant and 
24 complete bulbs with growing roots developed for each explant grown on the Medium 7. This medium contains 
NAA and BA as growth regulator and was used in the initial phase plant regeneration.
Characterization of the RbCYP96T and RbN4OMT genes. AmAl represent a large class of molecules 
present exclusively in this plant family. More than 300 different structures with a large range of biological activi-
ties have already been described. Although the initial part of the biosynthetic pathway has been described, most 
of the enzymes and the corresponding genes remain unknown17. The N4OMT and CYP96T gene sequences have 
only been identified in plants producing galanthamine. Molecules such as montanine have been well described 
for their biological activities however, molecular data date back from decades and the key genes of this pathway 
still need to be described to boost biotechnological and pharmaceutical studies.
The methyltransferase enzyme N4OMT is able to methylate norbelladine to form 4′-O-methylnorbelladine in 
Narcissus27. To identify the R. bifida N4OMT gene, we designed oligonucleotides based on the genomic sequence 
from close homologs of N4OMT in Narcissus (NpN4OMT1 to NpN4OMT4; Online Resource, Supplementary 
Material Fig. S1). For this gene, the oligonucleotides included the ATG and stop codons. R. bifida cDNA fragment 
(744 bp) was cloned and sequenced from several clones providing a unique full-length R. bifida N4OMT cDNA 
sequence. Our study demonstrates that a single N4OMT gene is expressed in R. bifida bulbs. The putative R. bifida 
N4OMT gene coding sequence shows respectively 93, 92, 92, 92 and 93% identity with the coding sequences of 
the NpN4OMT1 (KJ584561.1), NpN4OMT2 (KJ584562.1), NpN4OMT3 (KJ584563.1), NpN4OMT4 (KJ584564.1) 
and NpN4OMT5 (KJ584565.1) genes encoding the N. aff. pseudonarcissus N4OMT protein27; Online Resource, 
Fig. S1). The 239-amino acid R. bifida protein shows 92 to 93% identity to the Pseudonarcissus protein. Thus, 
the gene we cloned here represents the R. bifida Norbelladine 4′-O-Methyltransferase ortholog (RbN4OMT; 
GenBank: MH765575).
The CYP96T enzyme catalyzes the transformation of 4′-O-methylnorbelladine to noroxomaritidine, lead-
ing to the formation of noroxomaritidine derivatives, such as haemanthamine18 and montanine. To iden-
tify the CYP96T gene ortholog in R. bifida, we also aimed at designing oligonucleotides based on conserved 
regions of the Pseudonarcissus CYP96T1 gene. The coding sequence of this gene was 1539 bp long and encoded 
a 513 amino acids protein18. However, the N. pseudonarcissus highly homologous sequences corresponding to 
CYP96T3 (AMO65743.1), CYP96T2 (AMO65742.1) and Noroxomaritidine synthase Cytochrome P450 96T1 
(A0A140IL90.1) present in the Genebank did not allow defining conserved regions. Using genomic data from 
Lycoris, we found a partial genomic sequence homologous to the Pseudonarcissus CYP96T genes covering 415 bp 
of the 3′ part of the coding sequence. Using a combination of oligonucleotides specific of the CYP96T genes 
including the Lycoris sequence, we succeeded to amplify a Rhodophiala cDNA sequence covering 384 bp (166 
aa) of the putative R. bifida CYP96T sequence. This sequence covered 25% of the 3′ part of the Pseudonarcissus 
CYP96T1 coding sequence and showed 85% of nucleotide identity and 84% of identity (93% similarity) at the 
protein level relative to Pseudonarcissus CYP96T (AMO65743 18) (Online Resource, Fig. S2). The partial sequence 











1 (Sucrose 30 g/L) 32 bc 20 b 0 a 8 bc
2 (Sucrose 60 g/L) 12 bc 7 b 8 a 25 ab
3 (Sucrose 90 g/L) 40 b 0 b 0 a 4 bc
4 (NAA 5 mg/L + KIN 0.5 mg/L + BA 1 mg/L) 100 a 77 a 0 a 0 c
5 (2,4-D 1 mg/L + BA 1 mg/L) 88 a 76 a 0 a 0 c
6 (NAA 2 mg/L + BA 4 mg/L) 79 a 100 a 0 a 8 bc
7 (NAA 0.1 mg/L + BA 0.5 mg/L) 44 b 69 a 8 a 31 a
8 (NAA 1 mg/L + BA 2 mg/L) 100 a 78 a 0 a 7 bc
9 (NAA 0.1 mg/L + BA 5 mg/L) 0 c 0 b 0 a 20 abc
10 (NAA 2.5 mg/L + KIN 0.5 mg/L) 100 a 100 a 0 a 0 c
Table 3. Effects of different media on the callus and shoot formation percentage of R. bifida explants after 
20 and 60 days of treatment. Means with different letters in the same column are significantly different using 
Duncan test (p < 0.05).
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RbCYP96T and RbN4OMT gene expression in R. bifida. Studies initiated in the 80’s showed that alka-
loids may influence plant growth as growth stimulators and regulators. However, the most important function 
of AmAl is the protection of plant cells from physical stresses such as UV-light, heat, pathogens and herbivores. 
AmAl can also help the plant to adapt to its local environment38. To determine the developmental factors affect-
ing alkaloid production and accumulation we studied RbCYP96T and RbN4OMT transcripts accumulation in 
different organs and under different growing conditions. Gene expression analyses were performed on reverse 
transcribed RNA isolated from R. bifida roots, bulbs and leaves grown in greenhouse for wild plants or acclimated 
plants of in vitro regenerated plants, or from in vitro grown young plants.
Under the different growing condition tested, RbN4OMT was expressed in almost all tissues (Fig. 4a). The 
highest RbN4OMT gene expression level was found in bulbs of both young plants and acclimated plants. However, 
wild plants did not show significantly higher expression in bulbs. We believe that in the wild bulbs the expres-
sion remained basal due to the absence of cell division and vascular tissue formation when stem width growth is 
complete39. In the other organs tested, RbN4OMT gene expression was always lower relative to bulbs whatever 
the growing conditions. Almost no expression was detected in leaves of acclimated plants (Fig. 4). In order to 
obtain a better visualization of the RbN4OMT gene expression in R. bifida plants, the analysis was done using 
additional organs of the wild plants (old leaves and flowering stems, Fig. 4). This analysis indicates that this gene 
was similarly expressed in roots, bulbs, leaves, old leaves and flowering stems. These levels of expression detected 
in the wild plants may be correlated with the age of these plants and their developmental stages. All together these 
results suggest that the RbN4OMT gene was expressed in the growing tissues of the developing plants. During 
seedling growth and acclimation, the highest level of RbN4OMT expression might be linked to the methylation of 
Norbelladine (9) to form 4′-O-methylnorbelladine (10) in bulbs.
In R. bifida, the RbCYP96T gene was also expressed in the majority of the tissues and culture conditions 
analyzed (Fig. 4b). Maximum RbCYP96T gene expression was found in wild plant roots while in bulbs and old 
leaves, the expression was below the detection level. In young growing in vitro plants, the highest expression was 
detected in roots and bulbs followed by leaves. In acclimated plants the highest level of expression was detected 
in bulbs followed by roots and leaves.
This expression study shows that the RbN4OMTand RbCYP96Texpression patterns are correlated in roots and 
bulbs of the young and acclimated plants and suggests production of montanine in these organs, in agreement 
with its accumulation in the roots and bulbs of adult plants.
Montanine production in R. bifida organs. We wanted to correlate gene expression with AmAl pro-
duction. First, we evaluated the linearity of our HPLC-based quantification method by constructing three linear 
curves on three different days with solutions containing montanine in seven different concentrations ranging 
from 120 to 2200 μg/mL. The linearity curves showed good linear correlation (R² = 0.999 and linear equation 
y = 13 036 × −371 135). These standard curves were used for AmAl quantification in our extracts.
Figure 3. In vitro R. bifida regeneration: R. bifida regeneration process using twin-scales bulb explants. (A) 
Callus formation in control medium (sucrose 30 g/L); (B) Direct organogenesis in medium with sucrose 60 g/L; 
(C–G) Direct organogenesis and shoot regeneration in medium 7 (Medium 7: NAA 0.1 mg/L + BA 0.5 mg/L); 
(H) Bulb and root formation; (I) Shoots growing attached to the explant; (J) Shoot multiplication and bulb 
development; (K) Shoot multiplication in solid medium; (L,M) Bulb development and leaves growing in liquid 
medium; (N) Plant developed ready to acclimation in greenhouse. Bar = 1 cm.
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Montanine quantification (Table 4) showed the highest production in bulbs and roots of wild plants (3.53 and 
3.42 mg/g, respectively), followed by young plants bulbs (2.21 mg/g), young plants leaves (2.10 mg/g), acclimated 
roots and leaves (1.63 and 1.47 mg/g, respectively) plus wild plant leaves (1.42 mg/g). The lowest levels of monta-
nine were detected in young plant roots (1.19 mg/g) and in the old leaves (0.30 mg/g).
In wild plant tissues (Table 4) the amount of montanine in the bulbs and the roots (3.53 and 3.42 mg/g, respec-
tively), was about 2.5 times higher than in the leaves and the flowering stems (1.42 and 1.25 mg/g). The lowest 
yield was found in old leaves (0.30 mg/g) almost 12 times lower than the amount produced by bulbs.
Discussion
In this study we have shown that the GC-MS analysis allowed the detection of 21 different compounds and we 
confirmed that montanine was the most abundant AmAl detected in the different R. bifida organs. Some of the 
detected compounds represented intermediates of the montanine biosynthesis pathway.
Amaryllidaceae regeneration was mainly described for Narcissus confusus and Leucojum aestivum40–44. In 
studies using L. aestivum, embryogenesis occurred in presence of dicamba and picloram, in 30 and 100% of the 
explants, respectively. In L. aestivum, 2,4-D promoted greater callus proliferation and somatic embryogenesis by 
contrast to other auxins42. For N. confusus, the regeneration was obtained through meristematic callus formation 
using 3% sucrose with BA and kinetin. This resulted in the formation of globular calli that turned green and 
developed aggregates of young shoots, similarly to L. aestivum, in which it allowed growth of embryogenic nodu-
lar calli40,41. The largest number of regenerated L. aestivum plants42 was obtained using BA and meta-topolin and 
a combination of meta-topolin and thidiazuron to form complete plants. In this study42, plant formation from 1 g 
Figure 4. RbN4OMT and RbCYP96T relative gene expression in wild adult, young and acclimated plants. (a) 
RbN4OMT and (b) RbCYP96T relative transcript accumulations were normalized on RbACTIN gene expression 
and assessed in different plant organs and growing conditions in R. bifida. (a,b) Results represent means +/− 




Young plants Acclimated WT
Roots 1.19 D 1.63 BCD 3.42 A
Bulbs 2.21 B 1.26 D 3.53 A
Leaves 2.10 BC 1.47 BCD 1.42 CD
Old leaves na na 0.30 E
Stem na na 1.25 D
Table 4. Montanine content (mg/g) found in the organs of Rhodophiala bifida plants cultured in different 
growth conditions. *Means not followed by the same letter differ from each other by the Tukey test, at 5% error 
probability. Young plants: young growing in vitro plants; Acclimated: greenhouse acclimated regenerated plants; 
WT: greenhouse grown wild plants; nd: not analyzed.
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of embryos was the best in media enriched with meta-topolin or benzyladenine, however the use of thidiazuron 
and meta-topolin led to the highest quantity of normally developed plants44. In a study using Narcissus cultivars43 
addition of sucrose increased the explant survival and callus formation, and resulted in better organogenesis.
We present here a complete protocol for regeneration using R. bifida twin scales. The medium containing 
NAA (0.1 mg/L) and BA (0.5 mg/L) can induce shoot formation and together with a multiplication in solid 
medium supplemented with activated charcoal, results in the generation of plant clumps. When transferred to 
liquid medium these plant clumps develop bulbs with roots in absence of any regulators. Also, these micro-plants 
can be transferred to the greenhouse where they develop normally. We also present the necessary procedure to 
transfer in vitro plants to soil in a greenhouse. These conditions can be adopted for future large-scale productions.
In order to initiate the molecular characterization of the AmAl biosynthetic genes we identified the full-length 
RbN4OMT and the partial RbCYP96T P450 cDNA sequences. Also we provide functional primers for the 
Amaryllidaceae ACTIN gene suitable for R. bifida gene expression studies. We showed that the expression of the 
RbN4OMT gene was rather low in wild plants with similar expression between the organs evaluated. In these 
plants, the level of montanine was equivalent and relatively high in the root and the bulbs but lower in the old 
leaves. In agreement with the level of expression observed in bulbs of young growing in vitro or acclimated plants, 
we can hypothesize that the production of alkaloids takes place earlier during plant development. Similarly, in 
Lycoris sprengeri bulbs, the expression of genes involved in starch biosynthesis decreased as the bulb diameter 
increased45. In wild N. pseudonarcissus collected during the flowering season, the highest N4OMT expression was 
also detected in bulbs, followed by inflorescences (intermediate results) and leaves (close to zero)27. It should also 
be noticed that the molecules present in an organ might have been synthetized and transported towards other 
organs as observed in Narcissus Carlton46.
The RbCYP96T gene was expressed at high level in the wild roots but was below detection level in the bulbs 
and old leaves despite the high content of montanine in these organs. Since the bulb is an underground storage 
organ, it is possible that biosynthesis of the alkaloids occurs earlier during bulb development in order to protect 
carbohydrate resources of the plant against herbivores and microorganisms47,48. Alternatively, a second CYP96T 
gene might be expressed specifically in the bulbs of this plant and was not detected in our experiments. The young 
growing in vitro and acclimated samples presented intermediate expression levels for the RbCYP96T gene, prin-
cipally in roots and bulbs, in agreement with their intermediate alkaloid accumulation.
Thus, altogether the expression study of these two genes correlates with a synthesis starting in developing 
organs and with an alkaloid accumulation during growth resulting in the higher montanine content observed in 
roots and bulbs of this plant.
In a study carried out with N. pseudonarcissus L. cv. Carlton46, production of alkaloids in bulbs, roots and 
leaves was the highest before flowering and bulbs had the lowest concentrations of the compounds galanth-
amine, haemanthamine and narciclasine. In Lycoris aurea, alkaloid content increased during the growing season 
and the galanthamine content was the lowest in leaves and the highest in bulbs. For this plant, around 99.5% of 
galanthamine was detected in bulbs and roots, with the highest level identified in roots and bulbs at the time of 
leaves withering in autumn49. In Crinum macowanii, bulbs had also the highest alkaloid content, followed by 
roots, flower stalks and leaves50. These data show certain similarity to our results in which the highest montanine 
content was found in the adult roots and bulbs. Furthermore, in Leucojum aestivum, the alkaloid biosynthesis and 
content depend of the latitude as well as of soil fertility level51,52. Our results also suggest that R. bifida alkaloid 
accumulation depends on the plant developmental stage.
Our work provides new insights regarding the AmAl biosynthesis regulation and represents a first step 
towards a better understanding of the molecular characterization of the montanine biosynthetic genes in R. 
bifida, awaiting sequencing of this plant genome. Our gene expression study using several plant organs and var-
ious growing conditions represents a founding study for future research aiming to know how R. bifida gene 
expression and alkaloid production can be correlated and improved to increase the production of this important 
pharmaceutical compound using R. bifida.
Methods
plant material and in vitro culture. Rhodophiala bifida plants were collected in Pelotas (RS-Brazil) 
(Latitude: −31.7719; Longitude: −52.3425; err: ±51462 WGS84) in July 2015. The bulbs were separated, washed 
under running water, pre-disinfected in 2% sodium hypochlorite for 3 hours, washed in sterile water and dried at 
23 °C for 24 h. Bulbs were stored at room temperature and before transfer to in vitro culture or greenhouse, they 
were kept at 10 °C and low humidity. The seeds of R. bifida var. Spathacea were purchased commercially (Jelitto®, 
Germany).
For greenhouse culture, a low organic mix (~1:3 organic: inorganic) of soil: sand: perlite (25: 40: 35%) was 
used. Plants were watered twice a week and nutritive solution was applied each ten days. Plants were grown with-
out incident light.
Seed sterilization was performed in ethanol 70% for 1 min, in sodium hypochlorite 3% with tween 20 (two 
droplets per 100 mL) for 20 min. Seeds were washed 3 times in sterile water. For germination, seeds were placed 
on agar plates (10 g/L) at 20 °C (day) and 16 °C (night) for ten days in the dark. For young plants, seedlings were 
grown individually in glass tubes on ½ MS medium, sucrose 15 g/L, Plant Preservative MixtureTM (PPM®, Plant 
Cell Technology, Washington, DC, US) 200 μL/L and agar 7 g/L. The medium was renewed every three weeks.
Outer dark layers of in vitro cultured (IC) bulbs were removed before sterilization in 70% ethanol for 1 min, 
followed by different schemes of disinfection as indicated in the text: I) Sodium hypochlorite 2% (commercial 
bleach) during 30 min, II) heating water to 54 °C during 1 h and then transfer to hypochlorite 2% for 1 h36 and 
III) pre-disinfection in 2% sodium hypochlorite for 3 hours, washing in distilled and autoclaved water and oven 
drying at 23 °C for 24 h + sodium hypochlorite 8% (commercial bleach) during 30 min. Bulbs were washed three 
times in sterile water, dried on filter paper for 30 min and sectioned into 1 × 1.5 cm fragments for in vitro culture.
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Shoot induction from R. bifida bulbous explants was made on medium for Amaryllidaceae53, containing the 
macronutrients of the MS medium (Duchefa®, Haarlem, The Netherlands) plus inositol 100 mg/L, nicotinic acid 
0.5 mg/L, thiamine 0.1 mg/L, pyridoxine 0.5 mg/L, casein 1 g/L, glycine 2 mg/L, phytagel 2 g/L, sucrose 30 g/L 
(all chemicals purchased from Sigma, St. Louis, MO, USA) and PPM at 0.2 g/L, pH 5.5 and autoclaved at 121 °C, 
at 1 atm for 20 min. Growth Regulators (GR) were sterilized by filtration (Millipore® 22 μm; Merck KGaA, 
Darmstadt, Germany) and added after autoclaving (121 °C for 20 min) as follows: Medium 1 or control: sucrose 
30 g/L; Medium 2: sucrose 60 g/L; Medium 3: sucrose 90 g/L; Medium 4: NAA 5 mg/L + KIN 0.5 mg/L + BA 
1 mg/L; Medium 5: 2,4-D 1 mg 1 mg/L + BA 1 mg/L; Medium 6: NAA 2 mg/L + BA 4 mg/L; Medium 7: NAA 
0.1 mg/L + BA 0.5 mg/L; Medium 8: NAA 1 mg/L + BA 2 mg/L; Medium 9 NAA 0.1 mg/L + BA 5 mg/L and 
Medium 10: NAA 2.5 mg/L + KIN 0.5 mg/L (all the GR from Sigma, St. Louis, MO, USA). The explants were kept 
in a growth chamber for 60 days and evaluated for percentage of callus induction, shoots and bulbs per treatment.
After shoot growth, they were transferred to flasks containing culture medium for multiplication53 with some 
modifications. This medium consisted in MS medium base with the addition of inositol 100 mg/L, nicotinic acid 
0.5 mg/L, thiamine 0.5 mg/L, pyridoxine 0.5 mg/L, glycine 1 mg/L, agar 7 g/L, activated charcoal 5 g/L (Sigma, St. 
Louis, MO, USA), sucrose 30 g/L, and PPM at 0.2 g/L, pH 5.5. After the multiplication of the shoots, the plants 
were relocated to the same modified MS medium but liquid and without charcoal. The media containing the 
micro-plants were renewed every 3 weeks. Samples were collected after 30, 60 and 90 days of growth. After 90 
days in culture, the in vitro plants were acclimated to the greenhouse and after eight and six months the wild and 
acclimated plants, respectively, were harvested.
For alkaloids extraction, the plant material was oven dried at ± 40 °C and grinded. For gene expression analy-
sis by Quantitative Real Time-PCR, the samples were frozen in liquid nitrogen. Chemical and molecular analyses 
were carried out on roots, bulbs and leaf organs.
Gene expression analysis. Total RNA extractions and qRT-PCR reactions were performed as described by 
Berrabah and collaborators54.
Primer efficiencies were calculated with LinReg PCR: Analysis of Real-Time PCR Data, version 11.1. 
RbN4OMT and RbCYP96T gene expression were normalized, using RbACTIN as reference gene. These primers 
specifically designed to monitor R. bifida ACTIN gene expression were TCCATCATGAAGTGTGATGTTGATAT 
as forward primer and CCTCCAATCCAGACACTGTACTT as reverse primer.
To measure the expression of the RbN4OMT and RbCYP96T genes, the primers used were 
CTGCTTGGAATTCAAGCCCGA as forward primer and ATGCCCCTGGACCATCCGAA as reverse primer. 
For the RbN4OMT CGTCAGGGTTGGAGGAGCGAT (forward primer) and ATCGCTCCTCCAACCCTGACG 
(reverse primer) were used.
R. bifida cDNA Cloning. All the primers were designed based on CYP96T1 and N4OMT Amaryllidaceae 
sequences conserved at the amino acids and nucleotides level in publicly available sequences (NCBI; GenBank55). 
Sequence comparisons were done with Blast search (http://www.ncbi.nlm.nih.gov/BLAST/) using sequences 
from the Amaryllidaceae family, OMT and CYP96T as criteria. For the N4OMT the forward primer was 
ATGGGTGCTAGCATAGATGATTAT and the reverse primer TCAATAAAGACGTCGGCAAATAGT. 
For the CYP96T the forward primer was CCATGGCCACTTCTTCTTCAGCATG and the reversed primer 
CCTCACATGACTGATCTCTTTCTAA. PCRs were done using Phusion High-Fidelity DNA polymerase 
(Thermo Scientific, USA) in a protocol containing 1 pre-incubation cycle (95 °C, 5 min) and 35 amplification 
cycles [(denaturation: 95 °C, 30 s), (hybridization: 55 °C, 30 s), (elongation: 72 °C, 1 min)].
The PCR products were cloned in pGEM®-T Easy Vector (Promega, USA) and introduced in One Shot® 
TOP10 Chemically Competent E. coli for plasmid amplification (Promega, USA).
Plasmid inserts were sequenced using Eurofins Genomics facilities (Ebersberg, Germany).
Alkaloid extraction and HPLC analysis. The extraction of total alkaloids was performed according to56 
with small modifications. We used 100 mg of plant material and the extraction was initiated with 2% sulfuric acid 
(v/v) on an ultrasound bath for 4 hours. The samples were gravity filtered and the supernatant washed with ethyl 
ether (3 × 100 mL). The aqueous fraction was basified with 25% ammonium hydroxide (v/v) until pH 9. This basic 
aqueous solution was partitioned with ethyl acetate (3 × 100 mL). The organic residue was filtered on anhydrous 
sodium sulfate and the volume was reduced to the residue in a rotatory evaporator. The alkaloid rich residue was 
resuspended in methanol 2 mL, filtered through a 0.45 μm membrane (Millipore®) and analyzed.
Liquid chromatographic analyzes were performed on a Waters Alliance e2695 with a diode arrangement 
detector (PDAWaters 2998), and software Empower 3 HPLC (Waters®) for data acquisition and treatment. The 
chromatographic column employed was reverse phase (Synergi Polar Phenomenex®, 80 Å, 4 μm, 250 × 4.60 mm) 
and coupled to a reversed-phase pre-column (Security Guard Cartridges™ Fusion Phenomenex®; 4.0 × 3.0 mm). 
The elution system used was composed by trifluoroacetic acid (TFA) 0.01% (mobile phase A, v/v) and acetoni-
trile: TFA 0.08% (mobile phase B, v/v). The flow rate used was 0.5 mL min−1, temperature for the sample compart-
ment 20 °C and the gradient start with solvent A at 85% (0–13 min), 82% (2 min); 79% (2 min), 77% (2 min); 100% 
of solvent B (hold for 2 min), 85% of solvent A (for the next 2 minutes), totaling 22 minutes of analysis using the 
wavelength of 290 nm for the montanine quantification.
Alkaloid identification by GC-MS. About 100 mg of each sample were dissolved in 100 µL of methanol and 
injected directly into the GC-MS apparatus (Agilent Tecnologies 6890 N coupled with MSD5975 inert XL) operat-
ing in the EI mode at 70 eV. A Sapiens-X5 MS column (30 m × 0.25 mm i.d., film thickness 0.25 µm) was used. The 
temperature gradient performed was the following: 2 min at 100 °C, 100–180 °C at 15 °C/min, 180–300 °C at 5 °C/
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min and 10 min hold at 300 °C. The injector and detector temperatures were 250 °C and 280 °C, respectively, and 
the flow-rate of carrier gas (He) was 1 mL/min. A split ratio of 1:10 was applied and the injection volume was 1 µL.
Statistical analysis. For the chemical analysis, we used at least three biological replicates for all of the sam-
ples and two technical replicates. For the qRT-PCR, three biological replicates and two technical replicates were 
done. The data were analyzed using analysis of variance (ANOVA) and means tests were compared by Tukey test, 
with a 5% level of significance (p < 0.05).
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